10.74
Tyra Biosciences Inc Borsa (TYRA) Ultime notizie
(TYRA) On The My Stocks Page - Stock Traders Daily
Tyra Biosciences (TYRA) Expected to Announce Quarterly Earnings on Tuesday - Defense World
Tyra Biosciences stock hits 52-week low at $10.62 amid market challenges - Investing.com Australia
Tyra Biosciences stock hits 52-week low at $10.62 amid market challenges By Investing.com - Investing.com South Africa
Rhumbline Advisers Grows Stake in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
BALVERSA Adoption on the Rise: Meeting Unmet Needs in Advanced Urothelial Cancer | DelveInsight - GlobeNewswire Inc.
Tyra Biosciences, Inc. (NASDAQ:TYRA) Sees Large Growth in Short Interest - Defense World
Advanced Urothelial Carcinoma Clinical Trial Pipeline - GlobeNewswire
Advanced Urothelial Carcinoma Clinical Trial Pipeline Analysis Demonstrates 20+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight - GlobeNewswire
Non-Muscle Invasive Bladder Cancer Clinical and Non-Clinical - openPR
(TYRA) Investment Report - Stock Traders Daily
Tyra Biosciences: FGFR1/2 Driven AE Data Spooked The Market - Seeking Alpha
Brokerages Set Tyra Biosciences, Inc. (NASDAQ:TYRA) Price Target at $30.50 - Defense World
Tyra Biosciences (NASDAQ:TYRA) Hits New 12-Month LowTime to Sell? - MarketBeat
Tyra Biosciences, Inc. (NASDAQ:TYRA) Receives $30.50 Consensus Target Price from Analysts - MarketBeat
Tyra Biosciences stock hits 52-week low at $11.88 amid market shifts - Investing.com Canada
(TYRA) Investment Analysis - Stock Traders Daily
Tyra Biosciences Inc (TYRA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire
TYRA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Tyra Biosciences Inc and Encourages Investors to Contact the Firm Today! - ACCESS Newswire
Tyra Biosciences' (TYRA) Buy Rating Reiterated at HC Wainwright - MarketBeat
Tyra Biosciences (NASDAQ:TYRA) Given “Buy” Rating at HC Wainwright - Defense World
Tyra Biosciences (NASDAQ:TYRA) Stock Price Up 6.6%Here's What Happened - MarketBeat
Tyra Biosciences director Nina Kjellson sells $78,466 in stock - MSN
Tyra Biosciences director Nina Kjellson sells $74,323 in stock - MSN
Tyra Biosciences (NASDAQ:TYRA) Reaches New 52-Week LowShould You Sell? - MarketBeat
Nina S. Kjellson Sells 5,401 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA) Stock - MarketBeat
Exclusive: Tyra Biosciences Sets Ambitious 4-Conference Roadshow Including Prestigious Biotech on the Beach - StockTitan
Tyra Biosciences (NASDAQ:TYRA) Sets New 1-Year LowHere's What Happened - MarketBeat
An Analysis of Tyra Biosciences Inc (TYRA)’s Potential Price Growth - Knox Daily
Financial Fitness Check: Examining Tyra Biosciences Inc (TYRA)’s Key Ratios - The Dwinnex
How to Take Advantage of moves in (TYRA) - Stock Traders Daily
Tyra Biosciences (NASDAQ:TYRA) Reaches New 12-Month Low – Here’s What Happened - Armenian Reporter
Tyra Biosciences director Nina Kjellson sells $74,323 in stock By Investing.com - Investing.com Australia
TYRA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Tyra Biosciences Inc and Encourages Shareholders to Contact the Firm! - ACCESS Newswire
Director’s Stock Sale Unveils Major Moves at Tyra Bioscience! - TipRanks
Tyra Biosciences, Inc. (NASDAQ:TYRA) Receives $30.50 Average Price Target from Analysts - MarketBeat
Tyra Biosciences, Inc. (NASDAQ:TYRA) Receives $30.50 Consensus PT from Analysts - Defense World
Tyra Biosciences adds Adele Gulfo to board - MSN
Tyra Biosciences appoints new board member - MSN
Tyra Biosciences appoints new board member By Investing.com - Investing.com Australia
Tyra Biosciences Insider Ups Holding By 284% During Year - Simply Wall St
TYRA INVESTIGATION NOTICE: Kaskela Law LLC Announces Investigation of Tyra Biosciences, Inc. (TYRA) and Encourages Investors to Contact the Firm - ACCESS Newswire
Tyra Biosciences adds Adele Gulfo to board By Investing.com - Investing.com South Africa
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):